{"Content: ":"Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences [zh]. In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.[2] In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.[3] On 9 June 2021, The vaccine has been approved by the Chinese authorities.[1] This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.","Title":"Chinese Academy of Medical Sciences COVID-19 vaccine - Wikipedia","KeyID":"11113","URL":"https://en.wikipedia.org/wiki/Chinese_Academy_of_Medical_Sciences_COVID-19_vaccine"}